| Literature DB >> 18036348 |
Frank Erdmann1, Franziska Jarczowski, Matthias Weiwad, Gunter Fischer, Frank Edlich.
Abstract
The FK506-binding protein 38 (FKBP38) is a pro-apoptotic regulator of Bcl-2 in neuroblastoma cells. Hsp90 inhibits the pro-apoptotic FKBP38/CaM/Ca(2+) complex and thus prevents interactions between FKBP38 and Bcl-2. Here we show that Hsp90 increases cell survival rates of neuroblastoma cells after apoptosis induction. Depletion of FKBP38 by short interference RNA significantly decreased the anti-apoptotic effect of Hsp90 expression. In addition, the influence of high cellular Hsp90 levels was only observed in post-stimulation apoptosis that is sensitive to selective FKBP38 active site inhibition. Similar anti-apoptotic effects in neuroblastoma cells were observed after stimulation of endogenous Hsp90 expression. Hence, the inhibition of FKBP38 by Hsp90 participates in programmed cell death control of neuroblastoma cells.Entities:
Mesh:
Substances:
Year: 2007 PMID: 18036348 DOI: 10.1016/j.febslet.2007.11.037
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124